BPO 0.00% 0.3¢ bioprospect limited

chalk'n this down as a buy, page-15

  1. 2,176 Posts.
    I can't see why BPO wouldn't be a good long term investment, Termoline will be on the market in the near future and Bio-A is on the same path.

    SLA holders will benefit substantially, not to mention their Ropren sales should commence in force in 2010, and I reckon I'll try for some over the net as a preventative step for all the abuse my liver and brain has taken over the years.

    Exciting times ahead for both companies, and you never know when a merger might happen.
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.